US2010076297A1PendingUtilityA1

Electromagnetic interference immune tissue invasive system

Assignee: BIOPHAN TECHNOLOGIES INCPriority: Feb 20, 2001Filed: Dec 19, 2008Published: Mar 25, 2010
Est. expiryFeb 20, 2021(expired)· nominal 20-yr term from priority
A61N 1/37518A61N 1/37512H01R 13/5224A61N 1/056H01R 13/6464H01R 13/719A61N 1/3718H01R 2201/12H01R 13/6598A61N 1/086A61N 1/16
55
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An electromagnetic immune tissue invasive system includes a primary device housing. The primary device housing having a control circuit therein. A shielding is formed around the primary device housing to shield the primary device housing and any circuits therein from electromagnetic interference. A lead system transmits and receives signals between the primary device housing. The lead system is either a fiber optic system or an electrically shielded electrical lead system.

Claims

exact text as granted — not AI-modified
1 . A method of operating a magnetic resonance imaging unit for preventing failure of a tissue implantable device of a patient undergoing magnetic resonance imaging, comprising:
 (a) monitoring, by the magnetic resonance imaging unit, operations of the tissue implantable device of the patient undergoing magnetic resonance imaging;   (b) determining, by the magnetic resonance imaging unit, from the monitored operations, a quiet period for a tissue implantable device; and   (c) generating, by the magnetic resonance imaging unit, a magnetic resonance imaging pulse only during the determined quiet period of the tissue implantable device.   
   
   
       2 . The method as claimed in  claim 1 , wherein the implantable tissue device is a cardiac assist device.

Join the waitlist — get patent alerts

Track US2010076297A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.